Integrative analysis of Ewing’s sarcoma reveals that the MIF-CD74 axis is a target for immunotherapy

Abstract Background Ewing’s sarcoma (EwS), a common pediatric bone cancer, is associated with poor survival due to a lack of therapeutic targets for immunotherapy or targeted therapy. Therefore, more effective treatment options are urgently needed. Methods Since novel immunotherapies may address thi...

Full description

Saved in:
Bibliographic Details
Main Authors: Fangzhou He, Jiuhui Xu, Fanwei Zeng, Boyang Wang, Yi Yang, Jie Xu, Xin Sun, Tingting Ren, Xiaodong Tang
Format: Article
Language:English
Published: BMC 2025-01-01
Series:Cell Communication and Signaling
Subjects:
Online Access:https://doi.org/10.1186/s12964-024-02020-y
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832594570895949824
author Fangzhou He
Jiuhui Xu
Fanwei Zeng
Boyang Wang
Yi Yang
Jie Xu
Xin Sun
Tingting Ren
Xiaodong Tang
author_facet Fangzhou He
Jiuhui Xu
Fanwei Zeng
Boyang Wang
Yi Yang
Jie Xu
Xin Sun
Tingting Ren
Xiaodong Tang
author_sort Fangzhou He
collection DOAJ
description Abstract Background Ewing’s sarcoma (EwS), a common pediatric bone cancer, is associated with poor survival due to a lack of therapeutic targets for immunotherapy or targeted therapy. Therefore, more effective treatment options are urgently needed. Methods Since novel immunotherapies may address this need, we performed an integrative analysis involving single-cell RNA sequencing, cell function experiments, and humanized models to dissect the immunoregulatory interactions in EwS and identify strategies for optimizing immunotherapeutic efficacy. Results EwS is infiltrated by immunosuppressive myeloid populations, T and B lymphocytes, and natural killer cells. We found that SLC40A1 and C1QA macrophages were associated with a poor prognosis, whereas CD8+ T-cell infiltration was associated with a good prognosis. A comparative analysis of paired samples revealed that in tumors with a good chemotherapeutic response, macrophages presented increased antigen presentation and reduced release of protumor cytokines, whereas CD8+ T cells presented increased cytotoxicity and reduced exhaustion. An interaction analysis revealed a vast immunoregulatory network and identified MIF-CD74 as a crucial immunoregulatory target that can simultaneously promote M2 polarization of macrophages and inhibit CD8+ T-cell infiltration. Importantly, MIF blockade effectively reshaped the tumor immune microenvironment, turning cold tumors hot and inhibiting tumor growth. Conclusions Our integrative analysis revealed that the MIF/CD74 axis is a promising target for the treatment of Ewing sarcoma and provides a rationale for this novel immunotherapy.
format Article
id doaj-art-bdfbd84f406647e7ab813edc4037586a
institution Kabale University
issn 1478-811X
language English
publishDate 2025-01-01
publisher BMC
record_format Article
series Cell Communication and Signaling
spelling doaj-art-bdfbd84f406647e7ab813edc4037586a2025-01-19T12:33:03ZengBMCCell Communication and Signaling1478-811X2025-01-0123112110.1186/s12964-024-02020-yIntegrative analysis of Ewing’s sarcoma reveals that the MIF-CD74 axis is a target for immunotherapyFangzhou He0Jiuhui Xu1Fanwei Zeng2Boyang Wang3Yi Yang4Jie Xu5Xin Sun6Tingting Ren7Xiaodong Tang8Department of Musculoskeletal Tumor, Peking University People’s HospitalDepartment of Musculoskeletal Tumor, Peking University People’s HospitalDepartment of Musculoskeletal Tumor, Peking University People’s HospitalDepartment of Musculoskeletal Tumor, Peking University People’s HospitalDepartment of Musculoskeletal Tumor, Peking University People’s HospitalDepartment of Musculoskeletal Tumor, Peking University People’s HospitalDepartment of Musculoskeletal Tumor, Peking University People’s HospitalDepartment of Musculoskeletal Tumor, Peking University People’s HospitalDepartment of Musculoskeletal Tumor, Peking University People’s HospitalAbstract Background Ewing’s sarcoma (EwS), a common pediatric bone cancer, is associated with poor survival due to a lack of therapeutic targets for immunotherapy or targeted therapy. Therefore, more effective treatment options are urgently needed. Methods Since novel immunotherapies may address this need, we performed an integrative analysis involving single-cell RNA sequencing, cell function experiments, and humanized models to dissect the immunoregulatory interactions in EwS and identify strategies for optimizing immunotherapeutic efficacy. Results EwS is infiltrated by immunosuppressive myeloid populations, T and B lymphocytes, and natural killer cells. We found that SLC40A1 and C1QA macrophages were associated with a poor prognosis, whereas CD8+ T-cell infiltration was associated with a good prognosis. A comparative analysis of paired samples revealed that in tumors with a good chemotherapeutic response, macrophages presented increased antigen presentation and reduced release of protumor cytokines, whereas CD8+ T cells presented increased cytotoxicity and reduced exhaustion. An interaction analysis revealed a vast immunoregulatory network and identified MIF-CD74 as a crucial immunoregulatory target that can simultaneously promote M2 polarization of macrophages and inhibit CD8+ T-cell infiltration. Importantly, MIF blockade effectively reshaped the tumor immune microenvironment, turning cold tumors hot and inhibiting tumor growth. Conclusions Our integrative analysis revealed that the MIF/CD74 axis is a promising target for the treatment of Ewing sarcoma and provides a rationale for this novel immunotherapy.https://doi.org/10.1186/s12964-024-02020-yImmunotherapyImmune modulatoryEwing’s sarcomaT cellMacrophages
spellingShingle Fangzhou He
Jiuhui Xu
Fanwei Zeng
Boyang Wang
Yi Yang
Jie Xu
Xin Sun
Tingting Ren
Xiaodong Tang
Integrative analysis of Ewing’s sarcoma reveals that the MIF-CD74 axis is a target for immunotherapy
Cell Communication and Signaling
Immunotherapy
Immune modulatory
Ewing’s sarcoma
T cell
Macrophages
title Integrative analysis of Ewing’s sarcoma reveals that the MIF-CD74 axis is a target for immunotherapy
title_full Integrative analysis of Ewing’s sarcoma reveals that the MIF-CD74 axis is a target for immunotherapy
title_fullStr Integrative analysis of Ewing’s sarcoma reveals that the MIF-CD74 axis is a target for immunotherapy
title_full_unstemmed Integrative analysis of Ewing’s sarcoma reveals that the MIF-CD74 axis is a target for immunotherapy
title_short Integrative analysis of Ewing’s sarcoma reveals that the MIF-CD74 axis is a target for immunotherapy
title_sort integrative analysis of ewing s sarcoma reveals that the mif cd74 axis is a target for immunotherapy
topic Immunotherapy
Immune modulatory
Ewing’s sarcoma
T cell
Macrophages
url https://doi.org/10.1186/s12964-024-02020-y
work_keys_str_mv AT fangzhouhe integrativeanalysisofewingssarcomarevealsthatthemifcd74axisisatargetforimmunotherapy
AT jiuhuixu integrativeanalysisofewingssarcomarevealsthatthemifcd74axisisatargetforimmunotherapy
AT fanweizeng integrativeanalysisofewingssarcomarevealsthatthemifcd74axisisatargetforimmunotherapy
AT boyangwang integrativeanalysisofewingssarcomarevealsthatthemifcd74axisisatargetforimmunotherapy
AT yiyang integrativeanalysisofewingssarcomarevealsthatthemifcd74axisisatargetforimmunotherapy
AT jiexu integrativeanalysisofewingssarcomarevealsthatthemifcd74axisisatargetforimmunotherapy
AT xinsun integrativeanalysisofewingssarcomarevealsthatthemifcd74axisisatargetforimmunotherapy
AT tingtingren integrativeanalysisofewingssarcomarevealsthatthemifcd74axisisatargetforimmunotherapy
AT xiaodongtang integrativeanalysisofewingssarcomarevealsthatthemifcd74axisisatargetforimmunotherapy